Imunon’s (IMNN) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Imunon (NASDAQ:IMNN – Free Report) in a report published on Wednesday morning,Benzinga reports. HC Wainwright currently has a $14.00 target price on the stock. Separately, D. Boral Capital reaffirmed a “buy” rating and set a $29.00 price objective on shares of Imunon in a research report […]
